Delivery outcome after the use of meclozine in early pregnancy
Authors:
- 1 July 2003
- journal article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 18 (7) , 665-670
Abstract
In some countries, including Sweden, no risk is considered to exist with the use of meclozine for nausea and vomiting in pregnancy (NVP), but in other countries warnings against use during pregnancy...Keywords
This publication has 16 references indexed in Scilit:
- Use of antihistamine drugs in early pregnancy and delivery outcomeThe Journal of Maternal-Fetal & Neonatal Medicine, 2002
- Pregnancy Outcome Following First Trimester Exposure to Antihistamines: Meta-AnalysisAmerican Journal of Perinatology, 1997
- A birth weight for gestational age standard based on data in the Swedish Medical Birth Registry, 1985–1989European Journal of Epidemiology, 1995
- A Quality Study of a Medical Birth RegistryScandinavian Journal of Social Medicine, 1990
- Search for teratogenic risks with the aid of malformation registriesTeratology, 1987
- Meclizine in pregnancy in relation to congenital malformations.BMJ, 1978
- Maternal drug histories and congenital abnormalities.BMJ, 1977
- Associations between Drugs Administered during Pregnancy and Congenital Abnormalities of the FetusBMJ, 1971
- Experimental Teratology with MeclozinePharmacology, 1966
- Teratogenic Effects of Meclizine Hydrochloride on the RatScience, 1963